Back
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Vs. Aligos Therapeutics Industry Stock Comparison
Sell
39
FNGD
MicroSectors FANG+ Index -3X Inverse Leveraged ETN
Last Price:
$13.40
Seasonality Move:
-32.62%
Sell
29
ALGS
Aligos Therapeutics
Last Price:
$32.39
Seasonality Move:
-18.25%
Sell
39
MicroSectors FANG+ Index -3X Inverse Leveraged ETN (FNGD)
is a Sell
Is MicroSectors FANG+ Index -3X Inverse Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors FANG+ Index -3X Inverse Leveraged ETN [FNGD] share price is $14.44. The Score for FNGD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
FNGD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $30.05. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FNGD Stock Price Chart
What is MicroSectors FANG+ Index -3X Inverse Leveraged ETN's stock price today?
-
The MicroSectors FANG+ Index -3X Inverse Leveraged ETN share price today is $14.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNGD is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.05The current trend is moderately bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
FNGD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 54.4 | Buy |
| Chaikin Money Flow: | 917678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.52 - 14.08) | Buy |
| Bollinger Bands (100): | (14.5 - 23) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.14 | Buy |
| Relative Strength Index (14 RSI): | 41.89 | Sell |
| Chaikin Money Flow: | -263729 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.95 - 41.43) | Sell |
| Bollinger Bands (100): | (7.22 - 30.48) | Buy |
FNGD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.48 | Buy |
| 20-day SMA: | 13.11 | Buy |
| 50-day SMA: | 15.2 | Sell |
| 200-day SMA: | 24.5 | Sell |
| 8-day EMA: | 13.69 | Buy |
| 20-day EMA: | 13.66 | Buy |
| 50-day EMA: | 15.29 | Sell |
| 200-day EMA: | 31.58 | Sell |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.28 | Sell |
| 20-day SMA: | 38.13 | Sell |
| 50-day SMA: | 27.37 | Buy |
| 200-day SMA: | 17.35 | Buy |
| 8-day EMA: | 36.3 | Sell |
| 20-day EMA: | 36.12 | Sell |
| 50-day EMA: | 29.44 | Buy |
| 200-day EMA: | 20.26 | Buy |
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Earnings Growth & FNGD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||